MycoMedia™ One HepG2 Hepatocellular Carcinoma Expansion Media

Human HepG2 Hepatocellular Carcinoma Expansion Media is a high-performance culture medium specifically formulated to support the robust expansion and metabolic activity of HepG2 hepatocellular carcinoma cells [i]. This media provides essential nutrients, growth factors, and buffering agents to maintain optimal pH and cellular homeostasis, ensuring high cell viability and proliferation rates. 

HepG2 cells play a crucial role in liver function research, cancer metastasis studies, and toxicity screening by actively secreting major plasma proteins, including albumin, α2-macroglobulin, α1-anti-trypsin, and plasminogen. HepG2 Media is an excellent choice for drug metabolism studies, liver toxicity assays, and cancer biology research. 

Product Features: 

• Optimized for HepG2 cell expansion Supports high-density culture and metabolic stability. 
• Compatible with serum supplementation – Designed for use with customer-preferred animal-origin serum. 
• Enhanced cell attachment and growth – Promotes uniform monolayer formation while sustaining hepatic functionality. 
• Ideal for liver toxicity and cancer research – Supports HepG2 cells in various in vitro applications, including carcinogenesis studies and drug screening. 

Recommended Uses for HepG2 Expansion Media: 

• Expansion and maintenance of HepG2 hepatocellular carcinoma cells 
• Drug metabolism and hepatotoxicity screening 
• Liver disease modeling and regenerative medicine research